The Cannabis Conversation | Medical Cannabis | CBD | Hemp
Anuj Desai
All episodes
Best episodes
Seasons
Top 10 The Cannabis Conversation | Medical Cannabis | CBD | Hemp Episodes
Goodpods has curated a list of the 10 best The Cannabis Conversation | Medical Cannabis | CBD | Hemp episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to The Cannabis Conversation | Medical Cannabis | CBD | Hemp for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite The Cannabis Conversation | Medical Cannabis | CBD | Hemp episode by adding your comments to the episode page.
EPISODE #27 Entrepreneurship In The Cannabis Space with Saul Kaye from iCAN
The Cannabis Conversation | Medical Cannabis | CBD | Hemp
09/04/19 • 25 min
This week, we are joined by Saul Kaye, pharmacist, angel investor, cannabis expert and founder of iCAN. iCAN, based in Israel, creates advanced pharmaceutical medical cannabis brands and products. They own a portfolio of innovative companies across the entire global cannabis ecosystem and are behind CannaTech, the world's leading Cannabis conference.
Saul provides us with some amazing insights into entrepreneurship within the Cannabis Space, we speak about: what you need to become a successful entrepreneur, how to win over investors, the importance of founding teams, and more.
We really enjoyed this discussion with Saul. If you’d like to find out more about Israel Cannabis and for resources mentioned within the episode, click through to our show notes here: https://www.canverse.global/shownotes/episode-27-entrepreneurship-in-the-cannabis-space-with-saul-kaye-founder-of-ican⠀
⠀
⠀
You can also: ⠀
→ Listen to the episode on our website here http://bit.ly/2Wc9aiW, or catch the show on iTunes https://apple.co/2WdmPq7, or Spotify https://spoti.fi/2WePyuG.⠀
→ Follow us on Twitter https://buff.ly/2YFLv7T⠀
→ Follow us on Instagram https://buff.ly/2FMqOzB⠀
→ Like us on Facebook https://buff.ly/2GElGxR⠀
→ Subscribe on YouTube https://www.youtube.com/channel/UCj0nd0-r_GAZ7snWk39yCYA/?sub_confirmation=1
Episode Summary
- Saul comes from a science background, having worked as a retail pharmacist for many years before switching over to cannabis.
- Israel has the highest rate of cannabis patients in relation to the population and is currently experiencing a bottleneck in patient access.
- iCAN operates across the value chain in areas including genetics, research, growing, extracting, formulating products, image processing and AI for applications in cannabis.
- Saul became interested in the Cannabis industry when his business partner and friend Jason needed medical cannabis. As a pharmacist, Saul found this incredibly interesting and opened up Saul’s eyes and he realised that the plant had huge medical potential.
- Israel has had a medical cannabis program since 1996 and now have over 50,000 patients within it.
- When starting a cannabis business, it is fundamental that you know your numbers - you need to be able to demonstrate to investors that you have a firm grip and understanding of profit and loss.
- You also need to have an incredibly clear vision to win over investors. You will need a clear idea of where the business wants to go in the future, actionable points about how to get there, and a solid team to execute on the vision.
- If you are starting a business in order to solve a problem, make sure the problem actually exists. Afterall - nobody will buy your products or services if they don’t need them.
- There is nothing wrong with working across the value chain and becoming a vertically integrated company as long as you have the skills and expertise to pull it off. Often, business who operate this way will be able to make more profits and therefore impress investors.
- 50% or more of founders teams will break up. It is important to make sure that your founder's agreements are thorough and that each member of the team is pulling their weight so to speak.
- Israel is an incredibly forward-thinking country and there are a plethora of Israeli businesses who are leading within the Cannabis space. THC, CBD and the endocannabinoid system was discovered in Israel, and there have been many clinical trials and studies within the country.
- In Israel, all political parties support Cannabis, whether they
EPISODE #168 Cannabis and Traumatic Stress with Gary Roberts, Cannabis Entrepreneur and Host of Good Dudes Grow Podcast
The Cannabis Conversation | Medical Cannabis | CBD | Hemp
07/19/22 • 39 min
This week, we welcome Gary Roberts, firefighter, CEO of Promises Recovery, Inc. and Host of Good Dudes Grow Podcast.
We examine PTSD and traumatic stress, along with the evidence of how cannabis can help in a therapeutic way. Gary also shares his personal journey through grief, which ultimately led him to found a non profit recovery centre for those in need.
📚 VIEW SHOW NOTES AND EXTRAS:
www.canverse.global/shownotes/e168
The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.
Get in touch at www.luminorecruit.com/
About Gary Roberts
18-year active duty firefighter. Gary also has over 30 years of experience in the fitness industry, focusing on athlete coaching, physical recovery programs, and mental training for athletic performance. Given his background and ability to learn and overcome psychological and physical trauma, medical training, and understanding how the body can be adaptive to proper prevention and post-recovery protocols. Gary has founded Promises Innovative Recovery to become a mental and physical health leader using innovative therapeutics like plant-based medicine and psychedelics. PIR focuses continuously on moving the needle forward with new and successful programs to benefit those in need.
Timestamps
0:00 Welcome to The Cannabis Conversation
0:46 Gary’s personal background, work as a firefighter, and why he became involved in recovery
5:15 Gary’s entrepreneurial journey and starting his CBD brand Pure Body Zen
14:13 Gary’s motivations for starting his CBD brand, and the challenges faced using CBD as a firefighter
16:00 Introduction to traumatic stress, PTSD, and Gary’s experiences of this
19:38 Are there different types of PTSD?
22:21 How do first line responders and firefighters usually treat alcohol?
25:15 How can cannabis help with traumatic stress?
27:33 The balance of THC and CBD for therapeutic use
31:45 The use of MDMA for post traumatic stress
Resources
Connect with Gary on LinkedIn: https://www.linkedin.com/in/good-dudes-grow/
Follow Good Dudes Grow Podcast on Instagram: https://www.instagram.com/gooddudesgrowpodcast/
Follow Promises Innovative Recovery on LinkedIn: https://www.linkedin.com/company/promises-innovative-recovery/
Promises Recovery Centers’Website: www.promisesrecoverycenters.com
Promises Innovative Recovery’s Website: www.promisesinnovativerecovery.com
EPISODE #149 Project Twenty21 Update with Anne Katrin Schlag and Mags Houston from Drug Science
The Cannabis Conversation | Medical Cannabis | CBD | Hemp
01/26/22 • 43 min
This week we’re excited to welcome Mags Houston and Dr. Anne Katrin Schlag from Drug Science - independent science led drugs charity based in London.
Together, we explore how ProjectTwenty21 is progressing, some of the initial findings from the participating patient set, alongside digging into the true value of real-world data as a form of medical evidence opposed to randomised controlled trials.
The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.
Get in touch at www.luminorecruit.com/
📚 VIEW SHOW NOTES AND EXTRAS:
https://www.canverse.global/shownotes/e149
About Dr Anne Katrin Schlag - Head of Research at Drug Science
Dr Anne Katrin Schlag is a Chartered Psychologist and Head of Research at Drug Science (https://drugscience.org.uk). She leads the research for the Drug Science Medical Cannabis Working Group, focusing on controversies surrounding medical cannabis, the improvement of patient access, and the continued development of education and stakeholder communication about medical cannabis. Dr Schlag is currently working on progressing the scientific evidence base of medical cannabis to include Patient Reported Outcomes, observational studies (such as T21) and the application of Multi-Criteria Decision Analysis to assess the benefits and safety of medical cannabis.
She holds Honorary Fellowships at both Imperial College London and King’s College London, chairs the research subgroup of the Cannabis Industry Council, and is scientific advisor to the Primary Care Cannabis Network.
About Mags Houston - Head of T21 at Drug Science
As Head of Project Twenty21, Mags is the operational lead for Drug Science’s medical cannabis observational study, helping to raise awareness amongst patients and prescribers, build more evidence by attracting more patients and prescribers to actively join the project, and educate the public about the growing evidence surrounding medical cannabis for treating a range of conditions. Alongside her role on T21, she volunteers for Heroic Hearts Project UK, a not-for-profit that helps veterans suffering with PTSD by providing retreats and education in psychedelic therapy. She also curates and hosts events for The Psychedelic Society (UK) around drug policy, psychedelic science and mental health treatment. Mags’ mission is to shift the mainstream narrative around drugs by helping to provide education and challenging UK drug policy, so that therapies and medicines that are currently not accessible to patients might be made available on the NHS and prescribed to the people who desperately need them.
Resources
Drug Science’s Website: https://www.drugscience.org.uk
Project Twenty21: https://www.drugscience.org.uk/project-twenty-21/
Join Anne on LinkedIn: https://www.linkedin.com/in/anne-katrin-schlag-3886a4/
Join Mags on LinkedIn: https://www.linkedin.com/in/ACoAAAOCG4IBadL6I3LJNez4_WtaJaWoemfjZlQ/
EPISODE #146 Overview of European Cannabis with Antonio Costanzo, Chief Executive Officer at Curaleaf International
The Cannabis Conversation | Medical Cannabis | CBD | Hemp
01/10/22 • 41 min
In our latest episode, we’re joined by Antonio Costanzo - CEO of Curaleaf International. Curaleaf is a leading US multi-state operator, and Curaleaf International is Europe’s largest vertically integrated cannabis company.
We examine the developing demand for medical and recreational cannabis use across Europe, looking into the various referendums, pilot projects, and regulatory changes underpinning the liberalisation of cannabis across the continent.
📚 VIEW SHOW NOTES AND EXTRAS:
https://www.canverse.global/shownotes/e146
I’m really pleased to announce our new show sponsor - Lumino!
Lumino is a boutique HR Agency that specialises in building high performance teams for the European cannabis industry - working in three main verticals: Commercial, Medical and Plant Facing
About Antonio Costanzo - Chief Executive Officer, Curaleaf International
Antonio Costanzo is an experienced senior executive with a successful track record in public and private companies and in innovative, complex and highly regulated industries. Before co-founding EMMAC, now Curaleaf International, he was instrumental in the successful development of Nuuvera, a Canadian publicly listed cannabis company that was acquired by Aphria, in March 2018. He led the company’s development in Europe, Africa and South America.
Prior to focusing on the cannabis industry, he was Head of Public Policy and Government Relations at Uber in the key European markets. He formerly spent 10 years in the online gaming industry, at bwin, as Director of International Development and Regulatory Affairs, developing the group’s activities across Europe.
He served for 5 years as vice-Chairman and board Director at ESSA – Sport Betting Integrity. He started his career in the media industry, at Eurosport, where he launched and managed the Italian market. Fluent in 4 languages, he has developed an extensive political and business network across Europe.
Quotables
“But clearly cannabis shouldn't be treated as aspirin or as paracetamol. You know, it has some peculiarities that need to be taken into account and addressed. And I think that this is a challenge that we have as an industry is supporting regulators in identifying the ways that can make medical cannabis more accessible to patients.”
“Those of us who will be here in 10, 15, 20 years, we see this industry evolve dramatically in a way that is difficult to predict today. But clearly it's going to be one of the big worldwide industries that will shape the economy in the coming 10,15, 20 years.”
Resources
Curaleaf International’s Website: https://curaleaf.com/
Follow Antonio on LinkedIn: https://www.linkedin.com/in/antoniocostanzo/?originalSubdomain=uk
Follow Curaleaf on LinkedIn: https://www.linkedin.com/company/curaleaf
EPISODE #111 Cannabis As An Addiction Treatment with Dr. Joseph Morgan, Professor of Cannabis Education at University of The Sciences
The Cannabis Conversation | Medical Cannabis | CBD | Hemp
05/10/21 • 40 min
This week we’re pod-swapping with our friends over at The Cannabis Enigma podcast by Cannigma.
This episode features Dr. Joseph Morgan, Professor of Cannabis Education at University of The Sciences, Pennsylvania, USA. We explore the role of cannabis in addiction treatment, the problems that federal law poses to medical cannabis research, and cannabis treatment protocol for addiction.
Check out The Cannabis Enigma Podcast by Cannigma now: https://cannigma.com/podcast/
→ View full show notes, summary, and access resources from this episodehere:
https://www.canverse.global/shownotes/e111
About Dr. Morgan
Joseph J. Morgan, MD, AACM is a Professor of Cannabis Education at the oldest pharmacy school in the U.S.A., founded as Philadelphia College of Pharmacy in 1822 and now known as University of the Sciences. He is the author of the chapter on addiction in the reference book "Cannabis As Medicine” (CRC Press, Taylor and Francis). He’s also an advisor to Parea Bio Sciences, a grower processor in Pennsylvania, and to Undoo.com, marketer of an antidote for cannabis intoxication. A longtime cannabis industry consultant, he has a patent pending in cannabinoid drug development licensed to Nexien Bio Pharma.
Quotables
CBD will reduce cravings, whether it’s for cigarettes, whether it’s for heroin or cocaine. THC has impacts on the endogenous opioid system to get the body to release its own opioids like endorphins and enkephalins, which will help with withdrawal. 16:20
modern FDA approved medicines have moved to single APIs. Herbal medicine, including cannabis, has hundreds of APIs, active pharmaceutical ingredients, so to get it FDA-approved, you have to do some level of toxicology and safety studies on each of the chemical constituents.33:00
Resources
Join The Cannigma on LinkedIn: https://www.linkedin.com/company/thecannigma/
Join The Cannigma on Twitter: https://twitter.com/thecannigma
Follow The Cannigma on Instagram: https://www.instagram.com/thecannigma/
Subscribe to The Cannabis Enigma Podcast: https://podcasts.apple.com/il/podcast/the-cannabis-enigma/id1481452395
EPISODE #104 US Cannabis Legislation and Regulation in 2021 with Dr. Stuart Titus, CEO of Medical Marijuana Inc.
The Cannabis Conversation | Medical Cannabis | CBD | Hemp
03/18/21 • 43 min
This week we’re joined by Dr. Stuart Titus, CEO of Medical Marijuana Inc. - developers and retailers of cannabis-derived products, and the first-ever publicly traded cannabis company in the USA.
In this episode, we explore some of the current legislation and regulations governing the cannabis industry in the USA, including the SAFE Banking Act and FDA regulation.
→ View full show notes, summary, and access resources here: https://www.canverse.global/shownotes/e104
About Dr. Stuart Titus
Dr. Stuart Titus is a veteran of the financial services and medical healthcare industries with over thirty years of combined experience in each discipline. In the investment banking industry, Dr. Titus worked with well-regarded firms including A.G. Becker, Prudential-Bache Securities, and Credit Suisse-First Boston. After leaving Wall Street, Dr. Titus opened and operated his private physiotherapy practice specialising in microcurrent and stem cell therapeutic treatments.
Now, Dr. Titus, a 10-year pioneer of the cannabis industry, is the Chief Executive Officer of the first-ever publicly traded cannabis company in the United States, Medical Marijuana, Inc. Dr. Titus has been involved in all aspects of the medical marijuana and industrial hemp industries as he also oversees a robust portfolio of subsidiary and investment companies. Through his leadership, Medical Marijuana, Inc. became the first company to deliver cannabis brands across U.S. state lines and international borders, making hemp-derived cannabidiol (CBD) available across 50 states and in dozens of countries such as Mexico, Brazil, Paraguay, Argentina and many European nations.
Dr. Titus is a graduate of Rollins College in Winter Park, Fla., where he majored in Economics and minored in Business Administration. He earned his Ph.D. degree from the Open International University, which is a World Health Organisation (WHO)-chartered affiliate. He holds a Fellowship with the American Academy of Pain Management and clinical association with the American Association of Integrative Medicine.
Quotables
- ‘My eyes were opened when all of a sudden I was introduced to the world of CBD’ 02:40
- ‘We can see CBD and the non-psychoactive arena taking a larger and larger piece of the overall cannabis pie every year 19:00
- ‘Cannabis means votes’ 29:19
Resources
Follow Medical Marijuana Inc. on Twitter: https://twitter.com/mjna_inc
Follow Medical Marijuana Inc. on LinkedIn: https://www.linkedin.com/company/medical-marijuana-inc-/
Read about the FDA’s regulation of cannabis-derived products: https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd#approved
EPISODE #103 Medical Cannabis - A Mother's Story with Vera Twomey: Cannabis Advocate, Activist and Author
The Cannabis Conversation | Medical Cannabis | CBD | Hemp
03/10/21 • 37 min
This week we’re delighted to be joined by Vera Twomey, mother of Ava (who suffers from Dravet Syndrome, a rare form of epilepsy), medical cannabis advocate, activist, and author of ‘For Ava...’.
From the perspective of a mother and caregiver, Vera shares the difficulties and frustrations faced accessing cannabis in Ireland, the importance of access to medical cannabis for children, and the extreme lengths she went to to find medicine for her child.
About Vera
Vera Twomey has spearheaded the campaign for access to medical cannabis in Ireland firstly on behalf of her daughter Ava Barry and subsequently on behalf of thousands who continue to seek access to medication for their family members.
Vera's commitment and dedication to the advocacy for cannabis has become known across the UK Europe and North America. Vera has spoken within the House of Commons and The European parliament as well as all around the Rep of Ireland and Northern Ireland on the topic of medical cannabis.
Her extraordinary book "For Ava" details the struggle and dedication she exhibited to achieve access to medication for her daughter.
A regular speaker surrounding the issue of medical cannabis Vera Twomey can be credited with bringing the issue of cannabis into the public sphere in Ireland. Her exceptional determination and can-do attitude can be given significant credit for the positive changes made by the government to move the issue of cannabis in the Rep of Ireland forward.
From Cork County in Ireland Vera lives with her family and continues to lobby tirelessly for fair access to cannabis medicine for all.
→ View full show notes, summary, and access resources here:
https://www.canverse.global/shownotes/e103
Quotables
‘When we started on this journey we were so alone, we didn't know where to turn’ 30:40
‘I never intended to be known for issues surrounding cannabis, but when there are children involved... morally it is the right thing to do to share that with other parents to give them the opportunity to maybe find some improvement for their child’s life’ 31:17
Resources
Join Vera on Twitter: https://twitter.com/veras1
Buy Vera’s Book: https://www.amazon.co.uk/Ava-incurable-reluctant-activist-campaign/dp/1781176833
Dravet Syndrome UK: https://www.dravet.org.uk/
EPISODE #93 Cannabis and International Drug Policy with Kenzi Riboulet-Zemouli, Drug Policy Advocate and Researcher
The Cannabis Conversation | Medical Cannabis | CBD | Hemp
12/15/20 • 42 min
On this week’s show we’re joined by Kenzi Riboulet-Zemouli, drug policy advocate, leading researcher, president of FAAAT, and advisory board member of the European Industrial Hemp Association.
Kenzi gives us a high-level overview of international drug control, including the treaties and conventions which manage it, and the politics involved. We also take a look at the recent historic removal of Cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs.
→ View full show notes and summary here: https://www.canverse.global/shownotes/episode-93-cannabis-and-international-drug-policy-with-kenzi-riboulet-zemouli-drug-policy-advocate-and-researcher
About Kenzi
Based in Barcelona, Kenzi is a French-Algerian interdisciplinary researcher and advocate for sustainable drug policy reforms. He co-founded the French NGO NORML France and the think-tank FAAAT. Focused on Action research (matching scholars and citizens) as a catalyser for legal and social changes, Kenzi has been particularly involved in studying alternative pathways for Cannabis policy reform, linking international law with local grassroots initiatives. His work articulates around ethics, human rights aspects, fair trade components, and criteria of sustainability of legally-regulated use, production, and markets of internationally controlled and/or psychoactive plants, fungi, products or substances.
Quotables
[The vote] is the most powerful symbol that we have seen in drug policy so far and that we will see in the next decade 32:00
Resources
Follow Kenzi on LinkedIn: https://www.linkedin.com/in/teluobir/
Follow Kenzi on Twitter: https://twitter.com/teluobir?lang=en
Kenzi’s Website: https://kenzi.zemou.li/
Join Kenzi on Patreon: https://www.patreon.com/teluobir
EPISODE #90 Battling Cancer With Cannabis Featuring Michelle Kendall, Cannabis Advocate, Patient and Filmmaker
The Cannabis Conversation | Medical Cannabis | CBD | Hemp
11/26/20 • 36 min
On today’s show we’re joined by the incredibly brave Michelle Kendall - advocate, medical cannabis patient and creator of documentary 'Schedule 1'.
Michelle shares with us her incredible personal journey of using medical cannabis to manage ovarian cancer, including how a protocol of high dose THC shrunk the size of her tumour, kept her cancer in remission, and helped her manage symptoms.
→ View full show notes and summary here: https://www.cannabis-conversation.com/blogs/episode90
About Michelle
Michelle Kendall never expected to be a Cannabinoid Oncology pioneer, but after fighting terminal ovarian cancer for 5 years, that is where she landed. 3 years into her diagnosis she was introduced to Cannabis, and to her utter shock it shrank her tumour. A passion for science led her to peer reviewed pre-clinical literature, where she was astonished by the anti tumour properties of Cannabis compounds. Out of medical options, she hopes Cannabis will keep her in remission.
Quotables
We have to think of cannabis as a giant basket of pharmacology, there are 550 compounds, and it appears that so many of them are biologically pharmacologically active 26:35
If I was a graduate student right now, I would be getting myself trained up in cannabinoid pharmacology as fast as I could - it’s going to keep researchers busy for a decade 24:40
The fact that we have to fight so hard for the science of something that is so groundbreaking and saving people’s lives is just pathetic 25:35
Resources
Watch Schedule 1 Documentary: https://www.schedule1movie.com/
Follow Schedule 1 Documentary on Instagram: https://www.instagram.com/schedule1movie/
Follow Schedule 1 Documentary on Twitter: https://twitter.com/schedule1movie
EPISODE #152 The Impact of Cannabis on the Nicotine and Alcohol Markets with Spiros Malandrakis & Shane MacGuill from Euromonitor International
The Cannabis Conversation | Medical Cannabis | CBD | Hemp
02/16/22 • 45 min
This week we’re joined by previous guests Spiros Malandrakis & Shane MacGuill from Euromonitor International - the world's leading independent provider of strategic market research.
We examine the impact of the emergence of the cannabis industry on the legacy tobacco, nicotine, and alcohol markets, and how the sector may continue to disrupt these established global markets in the future.
The Cannabis Conversation is sponsored by Lumino - a boutique HR and Recruitment Agency specialising in building high performance teams for the European Cannabis Industry. They work in three main verticals: Commercial, Medical and Plant Facing.
Get in touch at www.luminorecruit.com/
📚 VIEW SHOW NOTES AND EXTRAS:
https://www.canverse.global/shownotes/e152
About Shane MacGuill - Global Lead, Nicotine and Cannabis
Shane MacGuill conducts research and provides strategic analysis on all aspects of the global tobacco, nicotine and cannabis industries - working with a range of stakeholders to map the potential evolution and intersection of these industries. Collaborating with a broad spectrum of industry players including international manufacturers and companies in the supply chain, he leads conversations on consumer and industry trends and strategic development. A frequent contributor to the mainstream and business media including CNBC, Reuters, the Economist, Bloomberg, the Financial Times, the Sunday Times and the Times of London.
About Spiros Malandrakis - Head of Research, Alcoholic Drinks and Cannabis
Spiros Malandrakis has been providing pioneering insights on the evolution, branding and innovation within the global alcoholic drinks industry for the past decade. One of the first analysts to highlight the parallels, opportunities and pitfalls for the nascent cannabis market and its intersection with other FMCG industries.
A key author in trade magazines and a frequent contributor to high profile business media such as Bloomberg, the BBC, the Financial Times, Reuters, the WSJ, Spiros is regular keynote speaker in some of the industry’s most sought after conferences, and a firm believer in irreverent, opinionated and independent analysis.
Resources
Euromonitor’s Website: https://www.euromonitor.com/
Connect with Spiros on LinkedIn: https://www.linkedin.com/in/spiros-malandrakis-36830446/
Connect with Shane on LinkedIn: https://www.linkedin.com/in/shanemacguill/
Show more best episodes
Show more best episodes
FAQ
How many episodes does The Cannabis Conversation | Medical Cannabis | CBD | Hemp have?
The Cannabis Conversation | Medical Cannabis | CBD | Hemp currently has 194 episodes available.
What topics does The Cannabis Conversation | Medical Cannabis | CBD | Hemp cover?
The podcast is about Cannabis, Entrepreneur, Medical, Investment, Nature, Podcasts, Science, Business, Alternative and Career Change.
What is the most popular episode on The Cannabis Conversation | Medical Cannabis | CBD | Hemp?
The episode title 'EPISODE #174: Cannabis Genetics and Breeding with Dr Gavin George, Co-founder of Puregene AG' is the most popular.
What is the average episode length on The Cannabis Conversation | Medical Cannabis | CBD | Hemp?
The average episode length on The Cannabis Conversation | Medical Cannabis | CBD | Hemp is 36 minutes.
How often are episodes of The Cannabis Conversation | Medical Cannabis | CBD | Hemp released?
Episodes of The Cannabis Conversation | Medical Cannabis | CBD | Hemp are typically released every 7 days, 2 hours.
When was the first episode of The Cannabis Conversation | Medical Cannabis | CBD | Hemp?
The first episode of The Cannabis Conversation | Medical Cannabis | CBD | Hemp was released on Feb 23, 2019.
Show more FAQ
Show more FAQ